Phio Pharma
(NASDAQ:PHIO)
$0.67
-0.0039[-0.58%]
At close: Apr 15
$0.67
0[0.00%]
After Hours: 9:07AM EDT
Consensus Rating1
Buy
Highest Price Target1
$4.00
Lowest Price Target1
$4.00
Consensus Price Target1
$4.00

Phio Pharma Stock (NASDAQ:PHIO), Analyst Ratings, Price Targets, Predictions

Phio Pharmaceuticals Corp has a consensus price target of $4, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on February 6, 2024, August 16, 2023, and June 14, 2021. With an average price target of $5.33 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 696.02% upside for Phio Pharmaceuticals Corp from these 3 analyst ratings.

Analyst Trend
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Phio Pharma

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/06/2024PHIOBuy Now
Phio Pharma
$0.67497.01%HC Wainwright & Co.
Vernon Bernardino
$6 → $4MaintainsBuyGet Alert
08/16/2023PHIOBuy Now
Phio Pharma
$0.67795.52%HC Wainwright & Co.
Vernon Bernardino
→ $6ReiteratesBuy → BuyGet Alert
06/14/2021PHIOBuy Now
Phio Pharmaceuticals
$0.67795.52%HC Wainwright & Co.
Vernon Bernardino
MaintainsBuyGet Alert

FAQ

Q

What is the target price for Phio Pharma (PHIO)?

A

The latest price target for Phio Pharma (NASDAQ: PHIO) was reported by HC Wainwright & Co. on February 6, 2024. The analyst firm set a price target for $4.00 expecting PHIO to rise to within 12 months (a possible 497.01% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Phio Pharma (PHIO)?

A

The latest analyst rating for Phio Pharma (NASDAQ: PHIO) was provided by HC Wainwright & Co., and Phio Pharma maintained their buy rating.

Q

When was the last upgrade for Phio Pharma (PHIO)?

A

There is no last upgrade for Phio Pharma.

Q

When was the last downgrade for Phio Pharma (PHIO)?

A

There is no last downgrade for Phio Pharma.

Q

When is the next analyst rating going to be posted or updated for Phio Pharma (PHIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phio Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phio Pharma was filed on February 6, 2024 so you should expect the next rating to be made available sometime around February 6, 2025.

Q

Is the Analyst Rating Phio Pharma (PHIO) correct?

A

While ratings are subjective and will change, the latest Phio Pharma (PHIO) rating was a maintained with a price target of $6.00 to $4.00. The current price Phio Pharma (PHIO) is trading at is $0.67, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch